Literature DB >> 3733865

Estrogen responsive creatine kinase in human breast cancer cells.

G Scambia, V Natoli, P B Panici, G Sica, S Mancuso.   

Abstract

The brain type (BB) isoenzyme of creatine kinase (CK) is a very sensitive marker of estrogen action in rat uterus and in experimental mammary tumors. In order to detect useful markers for estrogen dependent human breast cancer cell proliferation we measured CK levels and isoenzyme composition in the CG5 cells, an estrogen supersensitive variant of the MCF-7 human breast cancer cell line. Under basal conditions, CK-BB accounted for 10%-15% of total enzymatic activity, while the MM isoenzyme represented the overwhelming component. In cells cultured in the presence of 5% charcoal-treated fetal calf serum, physiological concentrations (0.1-1 nM) of estradiol increased CK-BB levels in a dose- and time-related fashion. The effect was specific for estrogens and was prevented by antiestrogens. Our results show that CK-BB is estrogen regulated in the CG5 cells and suggest a possible role for this enzyme as an additional marker of the hormonal responsiveness of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733865     DOI: 10.1007/bf00394935

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  18 in total

1.  Predicting response to endocrine therapy in human breast cancer: a hypothesis.

Authors:  K B Horwitz; W L McGuire
Journal:  Science       Date:  1975-08-29       Impact factor: 47.728

2.  Estrogen effects on uterine metabolism: reversal by inhibitors of protein synthesis.

Authors:  J Gorski; M S Morgan
Journal:  Biochim Biophys Acta       Date:  1967-11-21

3.  Estrogen stimulates cell proliferation and the increase of a 52,000 dalton glycoprotein in human breast cancer cells.

Authors:  S Iacobelli; G Scambia; V Natoli; C Natoli; G Sica
Journal:  J Steroid Biochem       Date:  1984-03       Impact factor: 4.292

Review 4.  Steroid hormone receptors in breast cancer treatment strategy.

Authors:  W L McGuire
Journal:  Recent Prog Horm Res       Date:  1980

5.  Identification of the major component of the estrogen-induced protein of rat uterus as the BB isozyme of creatine kinase.

Authors:  N A Reiss; A M Kaye
Journal:  J Biol Chem       Date:  1981-06-10       Impact factor: 5.157

6.  Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing.

Authors:  K B Horwitz; W L McGuire
Journal:  J Biol Chem       Date:  1978-11-25       Impact factor: 5.157

7.  Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer.

Authors:  M Namer; C Lalanne; E E Baulieu
Journal:  Cancer Res       Date:  1980-05       Impact factor: 12.701

8.  mRNA for the rat uterine estrogen-induced protein. Translation in vitro and regulation by estrogen.

Authors:  M D Walker; A M Kaye
Journal:  J Biol Chem       Date:  1981-01-10       Impact factor: 5.157

9.  Mammary cancer: selective action of the estrogen receptor complex.

Authors:  M Ip; R J Milholland; F Rosen; U Kim
Journal:  Science       Date:  1979-01-26       Impact factor: 47.728

10.  Enzyme induction by estrogen.

Authors:  A M Kaye
Journal:  J Steroid Biochem       Date:  1983-07       Impact factor: 4.292

View more
  5 in total

1.  Molecular analysis of two mammary carcinoma cell lines at the transcriptional level as a model system for progression of breast cancer.

Authors:  S Schiemann; M Schwirzke; N Brünner; U H Weidle
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

2.  Immunohistochemical localization of creatine kinase BB in primary breast cancer: correlation with estrogen receptor content.

Authors:  G Scambia; G Santeusanio; P B Panici; S Iacobelli; S Mancuso
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

3.  Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma.

Authors:  N Durany; J Joseph; O M Jimenez; F Climent; P L Fernández; F Rivera; J Carreras
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

4.  Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients.

Authors:  N Zarghami; M Giai; H Yu; R Roagna; R Ponzone; D Katsaros; P Sismondi; E P Diamandis
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

5.  Metabolic Profiling Comparison of Human Pancreatic Ductal Epithelial Cells and Three Pancreatic Cancer Cell Lines using NMR Based Metabonomics.

Authors:  Miki Watanabe; Sulaiman Sheriff; Kenneth B Lewis; Junho Cho; Stuart L Tinch; Ambikaipakan Balasubramaniam; Michael A Kennedy
Journal:  J Mol Biomark Diagn       Date:  2012-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.